Harmony Biosciences Presents New Analysis Of Clinical Impact For WAKIX® (pitolisant) At The SLEEP 2021 Annual Meeting
- Thursday, June 10, 2021, 7:10
- Environment
- Add a comment
PLYMOUTH MEETING, Pa., June 10, 2021 /PRNewswire/ — Harmony Biosciences Holdings, Inc. (“Harmony”) (Nasdaq: HRMY), a pharmaceutical company dedicated to developing and commercializing innovative therapies for patients living with rare neurological disorders who have unmet medical needs,…
About the Author
adminasapcorp has written 41816 stories on this site.